NCT01691261CompletedPhase 1
A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration
Phase 1, Open-label, Safety and Feasibility Study of Implantation of Pf-05206388 (human Embryonic Stem Cell Derived Retinal Pigment Epithelium (rpe) Living Tissue Equivalent) in Subjects with Acute Wet Age Related Macular Degeneration and Recent Rapid Vision Decline
Source: ClinicalTrials.gov · Last updated 22 Nov 2024
Brief summary (registry, in English)
Phase 1 trial of retinal pigment epithelium replacement in subjects with wet age-related macular degeneration in whom there is rapidly progressing vision loss
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- First submitted
- 19 Sept 2012
- Start date
- 14 Oct 2021
- Primary completion date
- 10 Oct 2023
- Lead sponsor
- Moorfields Eye Hospital NHS Foundation Trust
- Diseases
- Macular degeneration
- NCT number
- NCT01691261
- EudraCT number
- 2011-005493-37
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 9
- From 14 Oct 2021 to the primary completion date, 10 Oct 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with an investigational drug within 30 days (or as determined by the local requirement, whichever is longer) or 5 half-lives preceding the first dose of study medication.
- Current or previous significant other ocular disease in the study eye, as determined by the investigator.
Other
- Pregnant females; breastfeeding females; and females of childbearing potential.
Who the study is looking for
- Male and /or post-menopausal female subjects aged 60 years or above.
- Diagnosis of wet Age-related Macular Degeneration (AMD) plus rapid recent vision decline
- An informed consent document signed and dated by the subject or a legal representative.
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Moorfields Eye Hospital NHS Foundation Trust Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.